跳至主要内容
临床试验/NCT07285564
NCT07285564招募中不适用

Performance of 18F-FDG Micro-PET-CT in the Assessment of Surgical Margins in Head and Neck Cancer

Centre Henri Becquerel1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2025年11月7日最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
10
试验地点
1
主要终点
Evaluate the diagnostic performance of 18F-FDG micro-PET-CT in malignant ENT tumors compared to definitive histological analysis (gold standard).

研究概览

简要总结

The purpose of this study is to evaluate the diagnostic performance of 18F-FDG micro-PET-CT in malignant Head and neck cancer compared to definitive histological analysis (gold standard).

详细描述

In approximately 20% of cases, surgical margins are considered insufficient. The only tool currently available intraoperatively to assess the quality of surgical resection is the extemporaneous examination. This has a sensitivity of only 10%.

The objective is therefore to evaluate the performance of another tool, available intraoperatively, to help surgeons assess the quality of their resection. Currently, micro-PET-CT allows for the evaluation of surgical specimens (CE marking and FDA approval obtained). Its performance in the evaluation of surgical margins remains to be demonstrated. This is the subject of the present study.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Signed informed consent
  • Adult, male or female, aged 18 or over
  • Patient with a malignant tumor of the oral cavity, oropharynx, hypopharynx, larynx, sinuses, or salivary glands, regardless of lymph node status (any N) M0, operable
  • Member or beneficiary of a social security plan

排除标准

  • Child-Pugh C liver failure
  • Patients under guardianship, conservatorship, or legal protection
  • Patients deprived of their liberty
  • Pregnant or breastfeeding women
  • Hypersensitivity to 18F-FDG or any of its excipients (ethanol or water for injection)
  • Uncontrolled diabetes
  • Moderate to end-stage renal failure, stage IIIB to V (glomerular filtration rate less than 44 mL/min/1.73 m²)
  • Patients unable to understand the study for any reason or to comply with the trial requirements (language, psychological, or geographical issues).

结局指标

主要结局

Evaluate the diagnostic performance of 18F-FDG micro-PET-CT in malignant ENT tumors compared to definitive histological analysis (gold standard).

时间窗: Surgery

Estimate the performance of micro-FDG PET in defining surgical margins and compare with histology by measuring the number of quadrants affected by each technique on the surgical specimen

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验